Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00B3VWM098
| Stock Name / Fund | iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc |
| Issuer | Blackrock |
| Entity holding fund | iShares VII Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300Q7FFITMZ2PFZ28 |
| ETF Ticker | CUS1(GBX) LSE |
| ETF Ticker | CUSS(USD) LSE |
| ETF Ticker | SXRG(EUR) F |
| ETF Ticker | CSUSS.MI(EUR) CXE |
| ETF Ticker | CSUSSz(USD) CXE |
| ETF Ticker | CUSS.LS(USD) CXE |
| ETF Ticker | CSUSS(EUR) ETF Plus |
| ETF Ticker | CUS1.L(GBP) LSE |
| ETF Ticker | CUSS.L(GBP) LSE |
Holdings detail for LENZ
| Stock Name | LENZ Therapeutics Inc |
| Ticker | LENZ(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
Show aggregate LENZ holdings
News associated with LENZ
- Peek Under The Hood: ITOT Has 12% Upside
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-03 08:00:12
- TD Asset Management Inc Sells 68,172 Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ)
- TD Asset Management Inc decreased its stake in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) by 66.2% during the first quarter, Holdings Channel reports. The firm owned 34,828 shares of the company’s stock after selling 68,172 shares during the quarter. TD Asset Management Inc’s holdings in LENZ Therapeutics were worth $895,000 as of […] - 2025-08-05 04:37:17
- Noteworthy Wednesday Option Activity: META, CVNA, LENZ
- Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Meta Platforms Inc (Symbol: META), where a total volume of 348,474 contracts has been traded thus far today, a contract volume which is representative of approxi - 2025-07-16 17:13:46
- LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Recommendation of “Buy” by Analysts
- Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) have been assigned an average rating of “Buy” from the six research firms that are currently covering the stock, MarketBeat reports. Five analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year […] - 2025-06-26 03:10:50
- Harbor Capital Advisors Inc. Has $1.25 Million Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)
- Harbor Capital Advisors Inc. grew its holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) by 10.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 48,616 shares of the company’s stock after purchasing an additional 4,627 shares during the period. Harbor Capital Advisors Inc. […] - 2025-06-13 05:18:56
- Jane Street Group LLC Cuts Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)
- Jane Street Group LLC lessened its holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) by 34.0% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,938 shares of the company’s stock after selling 4,089 shares during the quarter. Jane Street Group LLC’s holdings in […] - 2025-06-05 04:15:01
- The Manufacturers Life Insurance Company Raises Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)
- The Manufacturers Life Insurance Company grew its holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) by 116.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 67,891 shares of the company’s stock after buying an additional 36,582 shares during the period. The Manufacturers […] - 2025-05-12 05:36:48
- LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Recommendation of “Buy” by Brokerages
- Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) have been given an average recommendation of “Buy” by the six analysts that are currently covering the company, Marketbeat reports. Five research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12 […] - 2025-05-07 02:34:51
- Geode Capital Management LLC Sells 3,998 Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ)
- Geode Capital Management LLC cut its stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 334,026 shares of the company’s stock after selling 3,998 shares during the period. Geode Capital […] - 2025-04-24 04:24:51
- LENZ Therapeutics (NASDAQ:LENZ) Shares Down 8.5% – Here’s Why
- LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report)’s share price fell 8.5% during trading on Monday . The company traded as low as $18.81 and last traded at $19.38. 351,716 shares traded hands during trading, an increase of 104% from the average session volume of 172,211 shares. The stock had previously closed at $21.18. Analyst […] - 2025-04-08 04:56:51
- Bank of New York Mellon Corp Trims Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)
- Bank of New York Mellon Corp cut its position in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) by 1.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 29,214 shares of the company’s stock after selling 428 shares during the quarter. Bank of New York Mellon Corp’s holdings in LENZ Therapeutics were […] - 2025-03-26 05:52:54
- TD Cowen Initiates Coverage on LENZ Therapeutics (NASDAQ:LENZ)
- Equities research analysts at TD Cowen began coverage on shares of LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The firm set a “buy” rating and a $60.00 price target on the stock. TD Cowen’s price target would suggest a potential upside of 135.11% from the company’s […] - 2025-03-20 04:48:55
- Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) Price Target at $35.40
- LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) has earned an average rating of “Buy” from the seven brokerages that are presently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target […] - 2025-02-06 04:06:45
iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc LENZ holdings
| Date | Number of LENZ Shares Held | Base Market Value of LENZ Shares | Local Market Value of LENZ Shares | Change in LENZ Shares Held | Change in LENZ Base Value | Current Price per LENZ Share Held | Previous Price per LENZ Share Held |
|---|
| 2025-09-26 (Friday) | 8,103 | USD 340,569 | USD 340,569 | | | | |
| 2025-09-25 (Thursday) | 8,103 | USD 324,363 | USD 324,363 | 0 | USD -8,184 | USD 40.03 | USD 41.04 |
| 2025-09-24 (Wednesday) | 8,103 | USD 332,547 | USD 332,547 | | | | |
| 2025-09-17 (Wednesday) | 8,051 | USD 339,994 | USD 339,994 | | | | |
| 2025-09-16 (Tuesday) | 8,051 | USD 332,426 | USD 332,426 | | | | |
| 2025-09-12 (Friday) | 7,999 | USD 330,639 | USD 330,639 | | | | |
| 2025-09-11 (Thursday) | 7,999 | USD 326,439 | USD 326,439 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projectionThe likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of LENZ
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 107,918 | 0 | 191,635 | 56.3% |
| 2025-09-18 | 182,304 | 3 | 237,309 | 76.8% |
| 2025-09-17 | 112,449 | 0 | 176,091 | 63.9% |
| 2025-09-16 | 63,557 | 6 | 91,465 | 69.5% |
| 2025-09-15 | 133,041 | 0 | 178,182 | 74.7% |
| 2025-09-12 | 75,544 | 0 | 152,968 | 49.4% |
| 2025-09-11 | 79,110 | 0 | 195,455 | 40.5% |
| 2025-09-10 | 117,643 | 5 | 189,211 | 62.2% |
| 2025-09-09 | 54,734 | 0 | 75,116 | 72.9% |
| 2025-09-08 | 90,214 | 5 | 188,823 | 47.8% |
| 2025-09-05 | 147,274 | 18,004 | 238,003 | 61.9% |
| 2025-09-04 | 50,822 | 0 | 79,557 | 63.9% |
| 2025-09-03 | 209,988 | 0 | 302,949 | 69.3% |
| 2025-09-02 | 90,180 | 1,081 | 126,670 | 71.2% |
| 2025-08-29 | 37,380 | 0 | 68,421 | 54.6% |
| 2025-08-28 | 100,737 | 0 | 132,841 | 75.8% |
| 2025-08-27 | 100,863 | 30 | 188,408 | 53.5% |
| 2025-08-26 | 128,252 | 0 | 180,370 | 71.1% |
| 2025-08-25 | 125,122 | 6 | 144,494 | 86.6% |
| 2025-08-22 | 146,798 | 58 | 347,004 | 42.3% |
| 2025-08-21 | 92,427 | 0 | 132,442 | 69.8% |
| 2025-08-20 | 95,609 | 16 | 193,277 | 49.5% |
| 2025-08-19 | 122,604 | 54 | 186,448 | 65.8% |
| 2025-08-18 | 181,256 | 200 | 314,022 | 57.7% |
| 2025-08-15 | 259,018 | 0 | 647,777 | 40.0% |
| 2025-08-14 | 201,443 | 8,000 | 276,741 | 72.8% |
| 2025-08-13 | 126,852 | 5,357 | 244,682 | 51.8% |
| 2025-08-12 | 219,268 | 8,625 | 420,470 | 52.1% |
| 2025-08-11 | 751,740 | 55,436 | 1,311,307 | 57.3% |
| 2025-08-08 | 391,109 | 0 | 570,450 | 68.6% |
| 2025-08-07 | 102,474 | 0 | 228,829 | 44.8% |
| 2025-08-06 | 84,936 | 39 | 111,865 | 75.9% |
| 2025-08-05 | 177,714 | 20 | 255,804 | 69.5% |
| 2025-08-04 | 144,377 | 0 | 195,756 | 73.8% |
| 2025-08-01 | 566,842 | 10,443 | 771,888 | 73.4% |
| 2025-07-31 | 41,362 | 1,753 | 58,250 | 71.0% |
| 2025-07-30 | 89,933 | 1,632 | 134,400 | 66.9% |
| 2025-07-29 | 73,727 | 0 | 144,052 | 51.2% |
| 2025-07-28 | 42,856 | 0 | 87,870 | 48.8% |
| 2025-07-25 | 59,765 | 49 | 109,649 | 54.5% |
| 2025-07-24 | 40,037 | 6 | 57,016 | 70.2% |
| 2025-07-23 | 50,604 | 0 | 88,713 | 57.0% |
| 2025-07-22 | 25,775 | 0 | 40,736 | 63.3% |
| 2025-07-21 | 29,878 | 0 | 40,255 | 74.2% |
| 2025-07-18 | 75,367 | 12 | 113,331 | 66.5% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.